Article Correctness Is Author's Responsibility: New Immunotherapy Target Discovered for Malignant Brain Tumors February 15, 2021 Author: Neuroscience News Category: Brain CancerThe article below may contain offensive and/or incorrect content. Disabling the CD161 pathway restores the T-cell's ability to attack gliomas and extends lifespan in animal models of brain cancer.